NAD metabolism in Salmonella typhimurium: isolation of pyridine analogue supersensitive (pas) and pas suppressor mutants.
Mutants of Salmonella typhimurium supersensitive to the nicotinic acid analogue 6-amino-nicotinic acid (6ANA) were isolated as unable to grow on what are normally subinhibitory concentrations of the analogue. The mutations were classified on the basis of their map positions as pasA (89-92 units), pasB (66-69 units), pasC (18-22 units), pasD (18 units) and pasE (55 units). The mutants exhibited a wide range of minimal inhibitory concentrations towards 6ANA, and several were affected in terms of growth. The data suggest that most of the mutations probably reside in genes whose products utilize nicotinamide adenine dinucleotide (NAD) as a cofactor, the altered gene products being more sensitive to internal 6-amino NAD concentrations. Secondary mutations which suppress the Pas- phenotype were found to reside in the following NAD-related loci; pncB, nadB and nadD. Two of the pncB mutants appear to be affected in the expression of NAPRTase while several of the nadB mutants are apparently insensitive to feedback inhibition by internal NAD concentrations.
D015120:6-Aminonicotinamide / Q000494:pharmacology; D002874:Chromosome Mapping; D002876:Chromosomes, Bacterial; D004251:DNA Transposable Elements; D005798:Genes, Bacterial; D005809:Genes, Regulator; D009154:Mutation; D009243:NAD / Q000378:metabolism*; D009525:Niacin / Q000031:analogs & derivatives / Q000494:pharmacology; D009537:Nicotinamide Mononucleotide / Q000378:metabolism; D010430:Pentosyltransferases / Q000378:metabolism; D010641:Phenotype; D012486:Salmonella typhimurium / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D013489:Suppression, Genetic; D014161:Transduction, Genetic
D004251:DNA Transposable Elements; D009243:NAD; D009537:Nicotinamide Mononucleotide; D009525:Niacin; D015120:6-Aminonicotinamide; C044559:6-aminonicotinic acid; D010430:Pentosyltransferases; C021864:nicotinate phosphoribosyltransferase